We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Access to patient record databases invaluable for medical research, say leading funders

7 September 2007

Better use should be made of electronic databases and patient records to help scientists understand patterns of health and disease in the population, say leading UK funders. However, they warn that it is essential to develop such studies in consultation with the public. Their call comes at the launch of a new initiative to support research that uses such information for health research purposes.

Electronic patient records and longitudinal cohort databases – which follow large groups of people over long periods of time, often decades –provide a rich data source with the potential to answer key questions in biomedical, clinical and public health research. The increase in the use of new electronic technologies, for example the NHS National Programme for Information Technology, is providing new opportunities for research in this area.

To take advantage of these opportunities, the Wellcome Trust, the UK's largest medical research charity, has today launched a new initiative together with the Engineering and Physical Sciences Research Council (EPSRC), the Economic and Social Research Council (ESRC) and the Medical Research Council (MRC).

"Personal data from large groups of individuals, followed over their lifetimes, is a valuable tool for identifying and tracking health and disease in populations," says Dr Mark Walport, Director of the Wellcome Trust. "Many of the greatest advances in medical practice have come from improved public health measures. We must take advantage of developments in technology and data management to conduct research that will lead to health benefit.

"But personal data is, by its very nature, both sensitive and private. We must be transparent about the use of personal data and develop trust that data will be handled confidentially, securely and safely. This requires debate, dialogue and a sound regulatory environment with proper transparency and accountability."

Research using the health or medical records of large numbers of people has already provided valuable information that has helped save lives. In the 1950s, Professor Sir Richard Doll established the link between smoking and lung cancer by surveying the smoking habits of 40 000 British doctors. More recently, the Medical Research Council and British Heart Foundation Heart Protection Study of 20 000 patients showed that cholesterol can be reduced by taking statins. UK Biobank, a major UK medical research initiative, is currently recruiting 500 000 people aged 40-69 from across the country with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses.

Chair of the Research Councils UK Executive Group, Professor Ian Diamond, commented: "With vast volumes of information being collected about each of us over our lifetimes, this research has the potential to have a huge impact on the lives of millions of people living within the UK. The research is vital to building further understanding on how, by involving and building confidence amongst the general public, this huge array of personal data can be used to benefit society."

Two recent reports on public attitudes to the use of personal data in research, commissioned by the Wellcome Trust 1 and the Medical Research Council 2 and carried out by the University of Surrey and Ipsos MORI respectively, indicated that people are willing to provide their personal data for research if they know why it is needed and have confidence in the integrity and confidentiality of the research process. However, the reports also uncovered "scepticism about guarantees of anonymity, based on people's experiences in their everyday lives of anonymity and confidentiality being breached through error, deliberate intrusion or lack of care."

"Establishing public confidence in this type of research is very important," says Dr Walport. "That is why we are encouraging research projects with an element of public engagement to allow the issues around the use of patient databases for research to be explored, and to raise awareness of the importance of such research for patient benefit and of the strict ethical and confidentiality processes in place."

The initiative is looking at three areas in particular:

1. Health research using electronic patient records and major longitudinal cohort databases, particularly in the areas of population health and disease burden, major determinants of health (biological, social, economic or cultural) and health impact and effectiveness of health interventions and policies, including clinical trials implemented through national health systems.

2. Training programmes and workshops for researchers in the use of complex patient record and cohort databases.

3. Professional and public engagement activities to explore issues around the use of patient databases for research, and raise awareness of the importance of such research for patient benefit.

Contact

Craig Brierley
Media Officer
Wellcome Trust
T
+44 (0)20 7611 7329
E
c.brierley@wellcome.ac.uk

Notes for editors

1. Armstrong V. et al, 'Public perspectives on the governance of biomedical research: a qualitative study in a deliberative context'; commissioned by the Wellcome Trust and carried out by the University of Surrey.

2. Ipsos MORI, 'The use of personal health information in medical research: general public consultation', commissioned by the Medical Research Council.

3. The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing.

4. The Engineering and Physical Sciences Research Council (EPSRC) is the UK's main agency for funding research in engineering and the physical sciences. The EPSRC invests around £740 million a year in research and postgraduate training, to help the nation handle the next generation of technological change. The areas covered range from information technology to structural engineering, and mathematics to materials science. This research forms the basis for future economic development in the UK and improvements for everyone's health, lifestyle and culture. EPSRC also actively promotes public awareness of science and engineering. EPSRC works alongside other Research Councils with responsibility for other areas of research. The Research Councils work collectively on issues of common concern via Research Councils UK.

5. The Economic and Social Research Council (ESRC) is the UK's largest funding agency for research and postgraduate training relating to social and economic issues. It supports independent, high quality research relevant to business, the public sector and voluntary organisations. The ESRC's planned total expenditure in 2007-08 is £181 million.At any one time the ESRC supports over 4,000 researchers and postgraduate students in academic institutions and research policy institutes.

6. The Medical Research Council (MRC) is dedicated to improving human health through excellent science. It invests on behalf of the UK taxpayer. Its work ranges from molecular level science to public health research, carried out in universities, hospitals and a network of its own units and institutes. The MRC liaises with the Health Departments, the National Health Service and industry to take account of the public's needs. The results have led to some of the most significant discoveries in medical science and benefited the health and wealth of millions of people in the UK and around the world.

Share |
Home  >  News and features  >  Media office  >  Press releases  >  2007  > Access to patient record databases "invaluable" for medical research
Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888